Medplus Health Services · NSE: MEDPLUS · BSE: 543427
Q3 FY22 results · Oct–Dec 2021
Medplus Health Services reported revenue from operations of ₹933.45 crore and net profit of ₹16.92 crore for Q3 FY22 (Oct–Dec 2021), on a consolidated basis.
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 933.45 | — | — | — | — |
| Other income | 7.33 | — | — | — | — |
| Total income | 940.79 | — | — | — | — |
| Profit before tax | 21.75 | — | — | — | — |
| Net profit for the period | 16.92 | — | — | — | — |
| Attributable to shareholders of the company | 17.17 | — | — | — | — |
| EPS, basic (₹) | 1.53 | — | — | — | — |
| Net margin (%) | 1.8 | — | — |
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 24.71 | — | — | — | — |
| Other income | 1.12 | — | — | — | — |
| Total income | 25.83 | — | — | — | — |
| Profit before tax | (1.21) | — | — | — | — |
| Net profit for the period | (1.21) | — | — | — | — |
| EPS, basic (₹) | (0.11) | — | — | — | — |
| Net margin (%) | -4.9 | — | — |
Consolidated
- Filed with BSE
- 17 Feb 2022, 15:12 IST
- Board meeting
- 14 Feb 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 17 Feb 2022, 15:12 IST
- Board meeting
- 14 Feb 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE